Advertisement

Loading...

H.U. Group Holdings, Inc.

4544.TJPX
Healthcare
Medical - Diagnostics & Research
¥3238.00
¥21.00(0.65%)
Japanese Market opens in 7h 0m

H.U. Group Holdings, Inc. (4544.T) Stock Competitors & Peer Comparison

See (4544.T) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
4544.T¥3,191.00-0.81%181.3B65.69¥48.58+3.49%
4694.T¥4,045.00-0.37%151.6B22.20¥182.21+2.66%
2395.T¥1,414.00-0.35%58.9B12.64¥111.84+3.09%
2309.T¥2,644.00+0.46%44.6B8.48¥311.89N/A
4671.T¥2,610.00+0.66%26.1B14.01¥186.23+4.33%
2397.T¥1,092.00+0.18%7.4B-59.64-¥18.31N/A
3386.T¥1,261.00+0.72%7.2B21.29¥59.22+3.59%
9776.T¥1,952.00-0.41%6.1B0.00¥27,381,640.00+1.18%
7707.T¥204.00-2.39%5.6B-156.92-¥1.30N/A
6090.T¥683.00-2.57%3.8B19.17¥35.63+2.14%

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

4544.T vs 4694.T Comparison April 2026

4544.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4544.T stands at 181.3B. In comparison, 4694.T has a market cap of 151.6B. Regarding current trading prices, 4544.T is priced at ¥3,191.00, while 4694.T trades at ¥4,045.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4544.T currently has a P/E ratio of 65.69, whereas 4694.T's P/E ratio is 22.20. In terms of profitability, 4544.T's ROE is +0.04%, compared to 4694.T's ROE of +0.06%. Regarding short-term risk, 4544.T is less volatile compared to 4694.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4544.T.Check 4694.T's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions